Pentoxifylline in ALS: a double-blind, randomized, multicenter, placebo-controlled trial. [electronic resource]
Producer: 20060705Description: 1786-7; author reply 1786-7 p. digitalISSN:- 1526-632X
- Amyotrophic Lateral Sclerosis -- drug therapy
- Data Interpretation, Statistical
- Double-Blind Method
- Humans
- Multicenter Studies as Topic
- Neuroprotective Agents -- administration & dosage
- Outcome Assessment, Health Care -- methods
- Pentoxifylline -- administration & dosage
- Placebo Effect
- Placebos
- Prognosis
- Randomized Controlled Trials as Topic
- Risk Assessment -- methods
- Risk Factors
- Survival Analysis
- Survival Rate
- Treatment Failure
No physical items for this record
Publication Type: Letter; Research Support, Non-U.S. Gov't; Comment
There are no comments on this title.
Log in to your account to post a comment.